My Publications

I am the author of well-cited articles in the medical literature covering numerous disciplines, and innovative health solutions for people with:

  • COVID-19
  • Pancreatic cancer
  • Prostate cancer
  • Hepatoblastoma
  • Thymic cancer
  • Breast cancer
  • Crohn’s disease
  • Gadolinium (MRI-contrast) toxicity
  • Ophthalmic disorders
  • Abdominal surgery
  • Immune thrombocytopenic purpura (ITP)

Rogosnitzky M, Berkowitz E, Jadad AR.
No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19.
JMIRx | Med 2020;1(1):e19583. [Full Article]

Rogosnitzky M, Okediji P, Koman I.
Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19.
[published online ahead of print, 2020 Jul 22]. Pharmacol Rep. 2020;1-8. [Pubmed] [Full Article]

Rogosnitzky M, Berkowitz E, Jadad AR.
Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point.
JMIR Public Health Surveill. 2020 May 13; 6(2): e19199. [Pubmed] [Full Article]

Chater C, Bauters A, Beugnet C, M’Ba L, Rogosnitzky M, Zerbib P.
Intraplatelet Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor: New Biomarkers in Carcinoembryonic Antigen-Negative Colorectal Cancer?
Gastrointest Tumors. 2018 Sep; 5(1-2): 32-37. [Pubmed] [Full Article]

El Amrani M, Clement G, Lenne X, Rogosnitzky M, Theis D, Pruvot FR, Zerbib P.
The Impact of Hospital Volume and Charlson Score on Postoperative Mortality of Proctectomy for Rectal Cancer: A Nationwide Study of 45,569 Patients.
Ann Surg. 2018 Nov; 268(5): 854-860. [Pubmed]

Chau A, Prodeau M, Sarter H, Gower C, Rogosnitzky M, Panis Y, Zerbib P.
Persistent perineal sinus after abdominoperineal resection.
Langenbecks Arch Surg. 2017 Nov; 402(7):1063-1069. [Pubmed]

Chater C, Terriou L, Duhamel A, Launay D, Chambon JP, Pruvot FR, Rogosnitzky M, Zerbib P.
Reemergence of Splenectomy for ITP Second-line Treatment?
Ann Surg. 2016 Nov; 264(5): 772-777. [Pubmed]

Raynaud K, Seguy D, Rogosnitzky M, Saulnier F, Pruvot FR, Zerbib Ph.
Conservative management of severe caustic injuries during acute phase leads to superior long-term nutritional and quality of life (QoL) outcome
Langebecks Arch Surg, 2016 ;401(1):81-7. [PubMed]

Rogosnitzky M. and Branch S.
Gadolinium-Based Contrast Agent Toxicity- A Review of Known and Proposed Mechanisms
BioMetals, 2016 ;29(3), 365-376. [PubMed] [Full Article]

Rogosnitzky Moshe, Isakov Itzhak, Wlassoff Wjatschesslaw, Ingram April, and Barishak Y. Robert.
Ocular Applications of Dipyridamole: A Review of Indications and Routes of Administration
Journal of Ocular Pharmacology and Therapeutics, 2015 ;32(2):83-9. [PubMed] [Full Article]

Bauters A, Rogosnitzky M, Hachulla E, Copin MC, Saudemont A, Zerbib P
Elevated Plasma Fibrinogen in Clinically Asymptomatic Unicentric Castleman’s Disease: A Case Report.
J Clin Exp Hematop, 2014 ;54(1):85-8. [PubMed] [Full Article]

Zerbib P, Vinet A, Rogosnitzky M, Truant S, Chambon JP, Pruvot FR.
Gastrocele Complicates the Course of Non-operated Severe Caustic Injuries: Operative Strategies.
World J. Surg, 2014 ;38(5): 1233-7. [PubMed]

Dalgleish A, Featherstone P, Vlassov V, Rogosnitzky M.
Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: a case report and review of the literature.
Invest New Drugs, 2014 [PubMed]

Carlock BH, Bienstock CA, Rogosnitzky M.
Pterygium: nonsurgical treatment using topical dipyridamole – a case report.
Case Rep Ophthalmol, 2014 ;5(1):98-103. [PubMed] [Full Article]

A Bauters, DJ Holt, P Zerbib, M Rogosnitzky.
Gallium nitrate induces fibrinogen flocculation: an explanation for its hemostatic effect?
Biometals, 2013 [PubMed]

Lebas A, Rogosnitzky M, Chater C, Colombel JF, Nachury M, Cortot A, and Zerbib Ph.
Efficacy of sacral nerve stimulation for poor functional results of J-Pouch ileoanal anastomosis: a pilot study.
Techniques in Coloproctology, 2013 [PubMed]

Ph Zerbib, R Caiazzo, G Piessen, M Rogosnitzky, C Séquier, D Koriche, S Truant, E Boleslawski, J-P Chambon, F Pruvot.
Outcome in porcine acellular dermal matrix reinforcement of infected abdominal wall defects – a prospective study.
2013 [PubMed]

Rogosnitzky M, Danks R, Holt D.
Intravenous Immunoglobulin for the treatment of Crohn’s disease (review).
Autoimmunity Reviews, 2012 [PubMed] [Full Article]

Rogosnitzky M, Danks R, Kardash E.
Therapeutic Potential of Tranilast, an Anti-allergy Drug, in Proliferative Disorders (review).
Anticancer Res, 2012 ;32(7): 2471- 2478. [PubMed] [Full Article]

Rogosnitzky M, Finegold MJ, McLauglin PJ, Zagon IS.
Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment.
Invest New Drugs, 2012 [PubMed]

Rogosnitzky M, Danks R.
The therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions (review).
Pharmacological Reports, 2011 ;63, 337-347. [PubMed] [Full Article]

Goodley PH, Rogosnitzky M.
The Effect of Gallium Nitrate on Arresting Blood Flow from a Wound.
Case Reports in Medicine, 2011 ;Article ID 819710. [PubMed] [Full Article]

Barken I, Geller J, Rogosnitzky M.
Prophylactic noscapine inhibits prostate cancer in a mouse model.
Anticancer Res, 2010 ;30(2):399-401. [PubMed] [Full Article]

Rogosnitzky M, Danks R
Validation of blood testing for K-ras mutations in colorectal and pancreatic cancer. A short review.
Anticancer Res, 2010 ;30(7):2943-2947. [PubMed] [Full Article]

PJ McLaughlin, M Rogosnitzky and IS Zagon.
Inhibition of DNA synthesis in mouse epidermis by topical imiquimod is dependent on opioid receptors.
Exp Biol Med (Maywood), 2010 ;235(11): 1292-99. [PubMed]

Zagon I, Donahue RN, Rogosnitzky M, McLaughlin PJ.
Imiquimod Upregulates the Opioid Growth Factor Receptor to Inhibit Cell Proliferation Independent of Immune Function.
Exp Biol Med (Maywood), 2008 ;233: 968-979. [PubMed]

Barken I, Geller J, Rogosnitzky M.
Noscapine inhibits human prostate cancer progression and metastasis in a mouse model.
Anticancer Res, 2008 ;28(6A):3701-3704. [PubMed] [Full Article]

Smith JP, Stock H, Bingaman S, Mauger D, Rogosnitzky M, Zagon IS.
Low-dose naltrexone therapy improves active Crohn’s disease.
Am J Gastroenterol, 2007 ;102(4):820-8. [PubMed]

Hurst WJ, M Rogosnitzky, PJ McLaughlin, and IS Zagon.
The stability of opioid growth factor ([Met5]-enkephalin) in solution using HPLC and photodiode array detection.
J. Liquid Chromatography & Related Technologies, 2006 ;29:1-7. [Journal]

Moshe Rogosnitzky and Rachel Danks
Testosterone for the Treatment of Mammary and Prostate Cancers: Historical Perspectives and New Directions
Advances in Cancer Management, 2012 ;ISBN: 978-953-307-870-0.

Moshe Rogosnitzky, Carol A Bienstock, Yitzchak Issakov, Aaron Frenkel
Topical Dipyridamole for Treatment of Pterygium and Associated Dry Eye Symptoms: Analysis of User Reported Outcomes
ISVER Conference Proceedings, 2016 [PDF]

T. Armaghany, G. Vahdati, S. Broline, R. Goshen, M. Rogosnitzky, E. Delpassand
Dramatic response with peptide receptor radionuclide therapy with 177Lu-DOTATATE and capecitabine in the treatment of metastatic thymic carcinoma
Journal of Nuclear Medicine, 2015 ;56 no. Supplement 2 2A-30. [Journal]

Raynaud, Kevin, Benoit Voisin, Dine Koriche, Moshe Rogosnitzky, Fabienne Saulnier, François-René Pruvot, Jean-Pierre Chambon, and Philippe Zerbib.
(Sa1953) Severe Gastric Caustic Injuries (SGCI)-Conservative Management During Acute Phase Leads to Superior Long-Term Quality of Life (QOL) and Nutritional Outcome.
Gastroenterology, ;144, no. 5 (2013): S-343.

Rogosnitzky M, Berkowitz E, Jadad AR.
No Time to Waste: Real-world Repurposing of Generic Drugs as a Multifaceted Strategy against COVID-19.
JMIR Preprints. 23/04/2020:19583; DOI: 10.2196/preprints.19583

Rogosnitzky, M, Okediji, PT, & Koman, I.
Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19.
OSF Preprints, 13 May 2020.